Investigates toxic compounds in chocolates and cocoa-free alternatives, indicating significant differences in amino acid effects.
This study investigated the influence of cocoa-bean amino acid profile on the formation of α,β-unsaturated carbonyls. Some of these heat-derived compounds generated primarily during roasting (often through Strecker degradation and aldol condensation) are of toxicological concern (e.g., the aneugenic 2-phenylcrotonaldehyde and the genotoxic furan-2(5H)-one). Here, their levels were compared by SAFE-GC/MS in cocoa of different origins, before and after roasting. Free amino acid profiles were determined by HPLC-MS/MS. All the investigated roasted beans showed similar total free amino acid contents (10.5–15.0 g·kg−1) and profiles, while α,β-unsaturated aldehyde levels differed markedly between samples, and reached >200 µg·kg−1 after roasting, indicating that amino acid availability alone does not govern their formation. Analysis of a commercial cocoa-free chocolate surrogate, however, revealed much lower amounts of both free amino acids (total 1.6 g·kg−1) and amino-acid-derived α,β-unsaturated aldehydes (total 11 µg·kg−1) than in chocolate, together with only traces of pyrazines (total 72 µg·kg−1). In contrast, furan-2(5H)-one was found at similar levels in chocolate and the cocoa-free product (56–79 µg·kg−1), confirming a completely different pathway where amino acids are not key reagents in its synthesis.
No takes yet. Share an insight, caveat, or question.
Dusart et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: